ENTO Stock Price and Chart — NASDAQ:ENTO - TradingView
2024-10-17 • Google News
Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal disease.